{"article_title": "Sebelius Gives Drug Makers a Shot in the Arm", "article_keywords": ["week", "scored", "sebelius", "shot", "help", "win", "sales", "drug", "makers", "patients", "insurance", "significant", "arm", "gives"], "article_url": "http://www.wsj.com/articles/SB10001424052702303843104579172090415391168", "article_text": "Drug makers scored a significant win last week in their effort to increase sales from the rollout of the health-care overhaul, when the Obama administration cleared a path for the companies to help pay patients' out-of-pocket costs of prescriptions.\n\nAt issue was whether drug makers could help cover the cost of copayments on brand-name drugs for patients who get insurance through the overhaul's new insurance exchanges. The...", "article_metadata": {"article.template": "snippet", "article.created": "2013-11-03T21:18:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "The Obama administration ruled that under the Affordable Care Act, drug makers can help pay prescription-drug costs for patients on health-care exchanges. Pharmacy-benefit managers object, saying it steers patients away from generic drugs.", "creator": "@Loftus", "image": {"alt": "Drug makers spend an estimated $4 billion a year on copayment assistance to patients", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "title": "Branded Drugs Chalk Up a Win Under Health Law", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702303843104579172090415391168&headline=Drug%20makers%20spend%20an%20estimated%20%244%20billion%20a%20year%20on%20copayment%20assistance%20to%20patients&weburl=http://www.wsj.com/articles/SB10001424052702303843104579172090415391168"}}, "page.site.product": "WSJ", "keywords": "AbbVie,ABBV,Amgen,AMGN,GlaxoSmithKline,GSK.LN,GSK,Roche Holding,ROG.VX,Pfizer,PFE,Eli Lilly,LLY,Merck &,MRK,Dan Mendelson,Jim McDermott,Leah Howard,Mark Merritt,marketing,branding,corporate,industrial news,content types,factiva filters,fc&e industry news filter,pharmaceuticals,insurance,non-life insurance,health,medical insurance,financial services", "news_keywords": "AbbVie,ABBV,Amgen,AMGN,GlaxoSmithKline,GSK.LN,GSK,Roche Holding,ROG.VX,Pfizer", "article.headline": "Drug makers spend an estimated $4 billion a year on copayment assistance to patients", "description": "The Obama administration ruled that under the Affordable Care Act, drug makers can help pay prescription-drug costs for patients on health-care exchanges. Pharmacy-benefit managers object, saying it steers patients away from generic drugs.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702303843104579172090415391168&headline=Drug%20makers%20spend%20an%20estimated%20%244%20billion%20a%20year%20on%20copayment%20assistance%20to%20patients&weburl=http://www.wsj.com/articles/SB10001424052702303843104579172090415391168", "user.type": "nonsubscriber", "article.page": "Business", "page.content.format": "responsive", "article.summary": "The Obama administration ruled that under the Affordable Care Act, drug makers can help pay prescription-drug costs for patients on health-care exchanges. Pharmacy-benefit managers object, saying it steers patients away from generic drugs.", "page.site": "wsj", "testkeys": "C", "article.published": "2013-11-04T00:12:00.000Z", "dj.asn": "i-65ef", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "embed_count": 2, "image_count": 1, "word_count": 885, "internal_link_count": 6}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "The Obama administration ruled that under the Affordable Care Act, drug makers can help pay prescription-drug costs for patients on health-care exchanges. Pharmacy-benefit managers object, saying it steers patients away from generic drugs.", "title": "Branded Drugs Chalk Up a Win Under Health Law", "url": "http://www.wsj.com/articles/SB10001424052702303843104579172090415391168", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Jonathan D. Rockoff and Peter Loftus", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Branded Drugs Chalk Up a Win Under Health Law", "article.type": "Business", "article.id": "SB10001424052702303843104579172090415391168", "user.exp": "default", "article.updated": "2013-11-04T00:12:00.000Z"}, "_id": "\"57477af46914bd0286fd9c42\"", "article_summary": "At issue was whether drug makers could help cover the cost of copayments on brand-name drugs for patients who get insurance through the overhaul's new insurance exchanges.\nDrug makers scored a significant win last week in their effort to increase sales from the rollout of the health-care overhaul, when the Obama administration cleared a path for the companies to help pay patients' out-of-pocket costs of prescriptions."}